BioCardia, Inc.: BioCardia Reports Third Quarter 2025 Business Highlights and Financial Results

BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, ...